An estimated two billion people lack the medicines they need. The 2016 Access to Medicines Index analyzes pharmaceutical companies’ efforts to improve access to medicines, vaccines and diagnostics for low- and middle-income countries.

Sabin Vaccine Institute President Dr. Peter Hotez gave the keynote address on NTDs at the Pontifical Council for Health Care Workers’ XXXI International Conference, focused on NTDs and rare diseases.

Last year, the leaders of some of the wealthiest nations pledged help control and eliminate the most common neglected tropical diseases (NTDs) by 2020.

This article was originally posted on the DSW Blog.

Photo: Sabin CEO Michael W. Marine, Ambassador (Ret.), with Former President of Ghana, John Kufuor

Sabin’s President, Dr. Peter Hotez, received the 2015 RESULTS Seeds of Hope Award on Sunday in Houston, Texas. Each year, this award honors a person in the Houston community who has made extraordinary contributions towards improving health, education or microfinance — the three pillars of RESULTS advocacy. This year’s award honored advances in Child and Maternal Health.
During the month of October, END7 student supporters are celebrating NTD Success Stories — spreading the exciting news that many countries around the world have already made incredible progress towards the control and elimination of some NTDs. In recent weeks, there have been many new successes to celebrate.

The initial research for the Ebola vaccine was published in 2003, where it sat for more than a decade waiting for a vaccine manufacturer to invest in licensing and development. Only after the 2014 outbreak began did the U.S.

by Peter Hotez, M.D., Ph.D. Hotez is Dean of the National School of Tropical Medicine at Baylor College of Medicine where he is also the Texas Children’s Hospital Endowed Chair in Tropical Pediatrics and the University Professor of Biology at Baylor University.

Pages